The clearance is a step forward in AstraZeneca and Daiichi Sankyo’s plan to position antibody-drug conjugates like Enhertu ...
January 2025 – AstraZeneca, a leading multinational pharmaceutical and biotechnology company, has been recognized as the second-best place to work across the Middle East for 2024 according to the ...